1
|
Zhang J, Bai J, Gong C, Wang J, Cheng Y, Zhao J, Xiong H. Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy. Front Oncol 2023; 13:1184626. [PMID: 37664062 PMCID: PMC10471886 DOI: 10.3389/fonc.2023.1184626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Accepted: 07/28/2023] [Indexed: 09/05/2023] Open
Abstract
Tumour metabolism is a major focus of cancer research, and metabolic reprogramming is an important feature of malignant tumours. Serine is an important non-essential amino acid, which is a main resource of one-carbon units in tumours. Cancer cells proliferate more than normal cells and require more serine for proliferation. The cancer-related genes that are involved in serine metabolism also show changes corresponding to metabolic alterations. Here, we reviewed the serine-associated one-carbon metabolism and its potential as a target for anti-tumour therapeutic strategies.
Collapse
Affiliation(s)
- Jing Zhang
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jian Bai
- Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Chen Gong
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jianhua Wang
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Yi Cheng
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jing Zhao
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Huihua Xiong
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
2
|
Govind N, Reynolds RJ, Hodkinson B, Ickinger C, Ramsay M, Bridges SL, Tikly M. HLA-DRB1 Amino Acid Positions and Residues Associated with Antibody-positive Rheumatoid Arthritis in Black South Africans. J Rheumatol 2018; 46:138-144. [PMID: 30385709 DOI: 10.3899/jrheum.180107] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/20/2018] [Indexed: 12/12/2022]
Abstract
OBJECTIVE To investigate the association of specific amino acid positions, residues, and haplotypes of HLA-DRB1 in black South Africans with autoantibody-positive rheumatoid arthritis (RA). METHODS High-resolution HLA-DRB1 genotyping was performed in 266 black South Africans with autoantibody-positive RA and 362 ethnically and geographically matched controls. The alleles were converted to specific amino acid residues at polymorphic sites for downstream analyses. Logistic regression models were used to test whether variability at site, specific amino acid residues, and haplotypes (constructed from positions 11, 71, and 74) were associated with RA. RESULTS Of the 29 amino acid positions examined, positions 11, 13, and 33 (permutation p = 3.4e-26, 1.2e-27, and 2.1e-28, respectively) showed the strongest association with RA. Univariate analyses of individual amino acid residues showed valine at position 11 (OR 5.1, 95% CI 3.7-7.0) and histidine at position 13 (OR 6.1, 95% CI 4.2-8.6) conferred the highest risk. The valine containing haplotypes of position 11, 71, 74, V_K_A conferred the most risk (OR 4.52, 95% CI 2.68-7.61) and conversely the haplotype with serine at this position, S_K_R, conferred the most protection (OR 0.83, 95% CI 0.61-1.15). CONCLUSION Autoantibody-positive RA in black South Africans is associated with histidine at position 13 and valine at position 11 of HLA-DRB1, and haplotypes with valine at position 11 conferred the highest risk; conversely, serine at position 11 conveyed protection.
Collapse
Affiliation(s)
- Nimmisha Govind
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa. .,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand.
| | - Richard J Reynolds
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa.,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand
| | - Bridget Hodkinson
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa.,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand
| | - Claudia Ickinger
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa.,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand
| | - Michele Ramsay
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa.,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand
| | - S Louis Bridges
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa.,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand
| | - Mohammed Tikly
- From the Division of Rheumatology, and Division of Human Genetics, Faculty of Health Sciences, and the Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; University of Cape Town, Cape Town, South Africa.,N. Govind, PhD, Division of Rheumatology, University of the Witwatersrand; R.J. Reynolds, PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; B. Hodkinson, PhD, University of Cape Town; C. Ickinger, MBBCh, Division of Rheumatology, University of the Witwatersrand; M. Ramsay, PhD, Sydney Brenner Institute for Molecular Bioscience, and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand;S.L. Bridges Jr., PhD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M. Tikly, PhD, Division of Rheumatology, University of the Witwatersrand
| |
Collapse
|